Literature DB >> 23297051

Possibility of transformation of primary myelofibrosis to ALL without JAK2V617F mutation.

Vladimir Jurisic, Sonja Pavlovic, Natasa Colovic, Milica Colovic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23297051     DOI： 10.1007/s12032-012-0398-2

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  5 in total

1.  Low JAK2V617F allele burden in primary myelofibrosis, compared to either a higher allele burden or unmutated status, is associated with inferior overall and leukemia-free survival.

Authors:  A Tefferi; T L Lasho; J Huang; C Finke; R A Mesa; C Y Li; W Wu; C A Hanson; A Pardanani
Journal:  Leukemia       Date:  2008-01-24       Impact factor: 11.528

2.  Long term follow up of 93 families with myeloproliferative neoplasms: life expectancy and implications of JAK2V617F in the occurrence of complications.

Authors:  Sandra Malak; Myriam Labopin; Cecile Saint-Martin; Christine Bellanne-Chantelot; Albert Najman
Journal:  Blood Cells Mol Dis       Date:  2012-07-19       Impact factor: 3.039

3.  Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.

Authors:  Ross L Levine; Martha Wadleigh; Jan Cools; Benjamin L Ebert; Gerlinde Wernig; Brian J P Huntly; Titus J Boggon; Iwona Wlodarska; Jennifer J Clark; Sandra Moore; Jennifer Adelsperger; Sumin Koo; Jeffrey C Lee; Stacey Gabriel; Thomas Mercher; Alan D'Andrea; Stefan Fröhling; Konstanze Döhner; Peter Marynen; Peter Vandenberghe; Ruben A Mesa; Ayalew Tefferi; James D Griffin; Michael J Eck; William R Sellers; Matthew Meyerson; Todd R Golub; Stephanie J Lee; D Gary Gilliland
Journal:  Cancer Cell       Date:  2005-04       Impact factor: 31.743

4.  RARS with fibrosis and del(20q) transformed into ALL.

Authors:  Sandra S Rohr; Luís Arthur Flores Pelloso; Aline dos Santos Borgo; João Garibaldi de Rezende; Maria Regina Regis Silva; Mihoko Yamamoto; Maria de Lourdes L F Chauffaille
Journal:  Med Oncol       Date:  2012-07-04       Impact factor: 3.064

Review 5.  Transformation of primary myelofibrosis with 20q- in Philadelphia-positive acute lymphoblastic leukemia: case report and review of literature.

Authors:  Vladimir Jurisic; Natasa Colovic; Tatjana Terzic; Vesna Djordjevic; Milica Colovic
Journal:  Pathol Res Pract       Date:  2012-05-31       Impact factor: 3.250
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.